We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioCision to Develop Controlled-Rate Cell Freezing Systems for Cook Regentec Cell Therapy Vials
News

BioCision to Develop Controlled-Rate Cell Freezing Systems for Cook Regentec Cell Therapy Vials

BioCision to Develop Controlled-Rate Cell Freezing Systems for Cook Regentec Cell Therapy Vials
News

BioCision to Develop Controlled-Rate Cell Freezing Systems for Cook Regentec Cell Therapy Vials

Read time:
 

BioCision, LLC today announced that they have entered into an exclusive partnership with Cook Regentec to develop two custom CoolCell® controlled-rate cell freezing systems for Cook’s closed-system cell therapy CellSeal® vials.

Cook selected BioCision’s proprietary CoolCell technology for its effectiveness in standardizing the freezing of cells and cellular therapies such as stem cells and tissue samples that can be used in a wide range of applications from diabetes research to organ transplants. The ease of implementation and use of CoolCell freezing systems, especially as compared to expensive controlled-rate freezers, will provide Cook’s CellSeal vial customers a cost-effective, reliable solution for controlled -1 degree Celsius per minute cell freezing, the rate believed to be optimal to ensuring cells remain intact and experience minimal negative effects during the freezing process. 

“Our CoolCell technology platform is ideal for customization into emerging formats, such as the CellSeal closed-system vial,” said Dr. Rolf O. Ehrhardt, CEO of BioCision.  “This partnership with Cook Regentec, a leader in the field of cell therapy, will enable users of these vials to standardize the cryopreservation of their cell therapy products. This is an important step forward for the industry and, most importantly, for the patients who rely on precise handling of these sensitive materials.”

This agreement encompasses the development of two customized cell freezing CoolCell systems for Cook’s CellSeal vials, as well as the adaptation of other BioCision technology platforms to this format, and is the latest in a series of customized products BioCision has developed for the cell therapy industry.

Advertisement